Quantcast

Latest ViroPharma Incorporated Stories

2014-06-16 08:29:08

Company will draw on leaders' expertise in rare diseases, R&D and commercialization as it moves to complete development of its lead program in inherited blindness PHILADELPHIA, June 16, 2014 /PRNewswire/ -- Spark Therapeutics, a late-stage gene therapy company developing treatments for a wide range of rare, debilitating diseases, announced today the appointments of Lars Ekman, former president of research and development at Elan, and Vin Milano, former president and CEO of...

2014-05-01 08:35:15

DUBLIN, May 1, 2014 /PRNewswire/ -- Shire (LSE: SHP, NASDAQ: SHPG) announces unaudited results for the three months to March 31, 2014. Financial Highlights Q1 2014 Growth(1) Product sales $1,308 million +19% Total revenues $1,347 million +18% Non GAAP operating income $591 million +40%...

2014-02-25 08:31:20

EXTON, Pennsylvania, February 25, 2014 /PRNewswire/ -- ViroPharma Incorporated today announced the results of its tender offer (the "Convertible Notes Tender Offer") pursuant to which each holder of the 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes") had the right (the "Fundamental Change Repurchase Right") to require ViroPharma to repurchase all of such holder's Convertible Notes, or any portion thereof that is a multiple of $1,000 principal amount, on...

2014-02-13 08:31:20

DUBLIN, February 13, 2014 /PRNewswire/ -- - Shire expects similar Non GAAP earnings per ADS growth in 2014 - Shire (LSE: SHP, NASDAQ: SHPG) announces unaudited results for the year to December 31, 2013. Financial Highlights Full Year 2013 (1) $4,757 Product sales million +12%...

2014-01-15 12:25:40

DUBLIN, January 15, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has waived the Office of Fair Trading (OFT) approval condition to the announced tender offer for all of the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM). As a result of the waiver, the transaction is no longer conditional on OFT approval, and Shire expects to complete the tender offer on January 24, 2014 following the currently scheduled expiration time, subject...

2014-01-10 04:20:37

DUBLIN, January 10, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has extended the expiration of its previously announced tender offer by a wholly owned subsidiary of Shire for all of the outstanding common shares of ViroPharma Incorporated (NASDAQ: VPHM) until midnight, New York City time, on Thursday, January 23, 2014 (one minute after 11:59 p.m., New York City time, on January 23, 2014). The tender offer had previously been scheduled to expire...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related